Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 |
| Revenues | 138.6 | 101.5 | 75.2 | 63.4 | 34.6 | 34.6 | 14.3 |
| Revenue growth | 36.6% | 34.9% | 18.7% | 83.3% | 142.4% | | |
| Cost of goods sold | 37.9 | 25.4 | 21.3 | 15.9 | 10.9 | 10.9 | 5.1 |
| Gross profit | 100.8 | 76.0 | 53.9 | 47.4 | 23.7 | 23.7 | 9.1 |
| Gross margin | 72.7% | 74.9% | 71.7% | 74.9% | 68.5% | 68.5% | 64.0% |
| Selling, general and administrative | 116.3 | 123.5 | 96.8 | 75.5 | 34.8 | 34.8 | 20.3 |
| Research and development | 36.4 | | | | 10.3 | 10.3 | 7.2 |
| EBIT | -52.0 | -47.5 | -42.9 | -31.4 | -21.4 | -21.4 | -18.4 |
| EBIT margin | -37.5% | -46.8% | -57.0% | -49.5% | -61.9% | -61.9% | -128.9% |
| Pre-tax income | 0.0 | -49.8 | -47.4 | -52.4 | -37.6 | -37.6 | -22.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | | | 0.0% | |
| Net income | 0.0 | -49.8 | -47.4 | -52.4 | -37.6 | -37.6 | -19.4 |
| Net margin | 0.0% | -49.1% | -63.0% | -82.7% | -108.9% | -108.9% | -135.8% |
| |
| Diluted EPS | $0.00 | ($1.44) | ($1.44) | ($2.28) | ($39.16) | ($39.16) | ($44.58) |
| Shares outstanding (diluted) | 35.8 | 34.6 | 33.0 | 23.0 | 1.0 | 1.0 | 0.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|